Cirrhosis-related changes in left ventricular function and correlation with the model for end-stage liver disease score

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5751-5757

  Li, Xiaopeng ^a   Yu, Shanshan ^a   Li, Lu ^a   Han, Donggang ^a   Dai, Shejiao ^a   Gao, Ya ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cardiac function; Cirrhotic cardiomyopathy; Echocardiography; Left; Liver cirrhosis

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD CLOTTING; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DECELERATION TIME; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEART VENTRICLE SEPTUM; HEPATITIS B; HEPATITIS C; HUMAN; INTERVENTRICULAR SEPTAL THICKNESS; KIDNEY FUNCTION; LEFT ATRIAL DIAMETER; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LEFT VENTRICULAR POSTERIOR WALL THICKNESS; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL FLOW VELOCITY; MIXED INFECTION; MODEL FOR END STAGE LIVER DISEASE SCORE; VIRUS INFECTION;

EID: 84921522196     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wiese S, Hove JD, Bendtsen F, Møller S. Cirrh-otic cardiomyopathy: pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2014; 11: 177-186.
2. Wiese S, Mortensen C, Gøtze JP, Christensen E, Andersen O, Bendtsen F, Møller S. Cardiac and proinflammatory markers predict prognosis in cirrhosis. Liver Int 2014; 34: e19-30.
3. Sun FR, Wang Y, Wang BY, Tong J, Zhang D, Ch-ang B. Relationship between model for end-stage liver disease score and left ventricular function in patients with end-stage liver disease. Hepatobiliary Pancreat Dis Int 2011; 10: 50-54.
4. Silvestre OM, Bacal F, de Souza Ramos D, And-rade JL, Furtado M, Pugliese V, Belleti E, An-draus W, Carrilho FJ, Carneiro D’Albuquerque LA, Queiroz Farias A. Impact of the severity of end-stage liver disease in cardiac structure and function. Ann Hepatol 2013; 12: 85-91.
5. Sampaio F, Pimenta J, Bettencourt N, Fontes-Carvalho R, Silva AP, Valente J, Bettencourt P, Fraga J, Gama V. Systolic and diastolic dysfunction in cirrhosis: a tissue-Doppler and speckle tracking echocardiography study. Liver Int 2013; 33: 1158-1165.
6. Abd-El-Aziz TA, Abdou M, Fathy A, Wafaie M. Evaluation of cardiac function in patients with liver cirrhosis. Intern Med 2010; 49: 2547-2552.
7. Kamath PS, Wiesner RH, Malinchoc M, Kre-mers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
8. Giannini E, Botta F, Fumagalli A, Malfatti F, Te-sta E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int 2004; 2: 465-470.
9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
10. Ripoll C, Catalina MV, Yotti R, Pérez-Peña J, Lo Iacono O, Rincón D, García-Fernández MA, Ber-mejo J, Bañares R. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008; 85: 1766-1772.
11. Busk TM, Bendtsen F, Møller S. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis. Eur J Gastroen-terol Hepatol 2013; 25: 523-530.
12. Pozzi M, Redaelli E, Ratti L, Poli G, Guidi C, Milanese M, Calchera I, Mancia G. Time course of diastolic dysfunction in different stages of chronic HCV related liver diseases. Minerva Gastroenterol Dietol 2005; 51: 179-186.
13. Pritchett AM, Mahoney DW, Jacobsen SJ, Ro-deheffer RJ, Karon BL, Redfield MM. Diastolic dysfunction and left atrial volumea population-based study. J Am Coll Cardiol 2005; 45: 87-92.
14. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gas-troenterol 2009; 104: 2458-2466.
15. Han DG, Zhao XL, Lei XY. Left ventricular function of cirrhosis observed by color Doppler echocardiac image. Chin J Med Imag Techn 2002; 18: 203-204.
16. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009; 361: 1279-1290.
17. Nazar A, Guevara M, Sitges M, Terra C, Solà E, Guigou C, Arroyo V, Ginès P. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction. J Hepatol 2013; 58: 51-57.